Toward development of tumor-specific chemotherapy, we designed a new type of liposomes with temperature-triggered drug release and magnetic resonance imaging (MRI) functions.
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efficient chemotherapy optimized to each patient.
Introduction
Toward establishment of safe and effective tumor therapy, accurate drug delivery is a promising approach, which enables to attack specifically the target malignant cells with drugs [1] [2] [3] . Regarding improvement of tumor specificity of drug delivery, efficient strategies are the use of nano-sized particles with a long circulation property with stimuli-sensitive properties as drug carriers. The former can improve accumulation of the carriers in tumor tissues through the enhanced permeation and retention (EPR) effect [4, 5] and the latter can increase therapeutic effect by releasing drug specifically at the diseased tissues upon application of stimuli to the target sites [6] [7] [8] . In addition, another important function for the improvement of accuracy of drug delivery might be imaging function of carriers [9] [10] [11] [12] [13] [14] . If drug carriers have these functions and properties, efficient cancer chemotherapy can be achieved by following accumulation of carriers to the target sites and triggering drugs by stimuli application after the maximum acculturation of the carriers at the targets sites. In addition, accumulation process of the carriers should vary depending on individual patient. Therefore, carriers with these functions should lead to personalized chemotherapy, which is optimized to each patient.
Recently, efforts have been made to provide imaging functions to various types of carriers by incorporating various types of imaging probes, such as quantum dots [15] [16] [17] , magnetic iron oxide nanoparticles [11,12,18,] and radionuclide 18 F [19, 20] have been incorporated to drug carrier materials for fluorescence imaging, magnetic resonance imaging (MRI), and positron emission tomography (PET) imaging, respectively. Among them, MRI is advantageous from the view points of image of high resolution and no exposure to radiation.
Also, MRI has no time limit for detection in contrast to PET with 18 F whose half-life is 109.8 min. Therefore, MRI is one of the best methods for visualization of drug delivery systems in the body from the practical sense.
Among various types of drug delivery systems, liposomes are of importance as drug delivery vehicle from the viewpoints of biodegradability, size-controllability and high drug encapsulation ability. In addition, stimuli-responsive functions can be provided to liposomes by using temperature-induced phase transition of the liposome membranes [21] [22] [23] [24] or incorporating temperature-sensitive polymers into the liposome membrane [25] [26] [27] [28] [29] [30] [31] .
Based on these advantages of liposomes, many attempts have been made to provide MR imaging functions to them [14] . Considering that the liposome lumen must be used to encapsulate large amounts of drug molecules, the membrane moiety might be suitable for the incorporation of MRI probes. Therefore, lipid-based MRI contrast agents, such as amphiphilic Gd-DTPA derivatives [32, 33] have been used for this purpose. Because these molecules contain single Gd-chelate moiety per molecule, inclusion of a high content of these amphiphilic Gd-chelate molecules might be necessary in the liposomes to gain high detectability with MRI, which should affect performance of the liposomes. Also, 6 macromolecular Gd-chelates, which have several Gd-chelate residues in the single molecular chain, have been incorporated to liposomes [13, 34, 35] . However, incorporation of such macromolecular polychelates taking on a extended structure may affect surface property of the liposomes.
In order to obtain multi-functional liposomes which exhibit both highly stimuli-responsive drug release and highly detectable MR imaging functions, we designed biocompatible pegylated liposomes having both highly thermosensitive polymers and amphiphilic poly(Gd-chelates) with a compact conformation. For this purpose, in this study, we newly synthesized polyamidoamine (PAMAM) G3 dendron-based lipids having eight Gd 3+ chelate residues (G3-DL-DOTA-Gd). Because of the highly branched backbone structure with many chain terminals, the dendron moiety taking on a compact conformation can hold many Gd-chelate residues. Based on the highly temperature-responsive liposomes, which were developed recently by modification of pegylated liposomes with thermosensitive poly
with a lower critical solution temperature (LCST) around 40°C [36, 37] , we incorporated the dendron-based lipid having many Gd-chelates into the poly(EOEOVE-block-ODVE)-modified liposomes ( Figure 1 ). Performances of the liposomes from the sense of visualization and tumor-chemotherapy were investigated. Importance of the visualization of accumulation process of the liposomes at the tumor sites and the heat-triggered drug release function of the liposome to achieve a highly reliable and efficient 7 chemotherapy was described.
Materials and Methods

Materials
Egg PAMAM G1 and G3 dendron-based lipids (G1-DL and G3-DL) were synthesized as reported previously [38] . Copoly[EOEOVE-block-octadecyl vinylether(ODVE)] was synthesized as previously reported using 1-(ethoxy)ethyl acetate as the initiator [36] . The number average molecular weight and polydispersity index of copoly(EOEOVE-block-ODVE) were estimated to be 1.3x10 4 and 1.03, respectively, using gel permeation chromatograpy. The number average molecular weights of poly(EOEOVE) block and poly(ODVE) block were estimated to be 87 and 7, respectively, using 1 H NMR. The copolymer was shown to undergo a transition between 36 and 46 °C with a peak at 38.2°C using DSC.
Animals
Female BALB/c mice were purchased from Oriental Yeast Co., Ltd. (Tokyo, Japan) and Japan SLC, Inc. (Shizuoka, Japan). Experiments were carried out in accordance with the guidelines for animal experimentation in Osaka Prefecture University and National Institute of Radiological Sciences.
Synthesis of G3-DL-DOTA and G1-DL-DOTA
G3-DL-DOTA was synthesized as follows. G3-DL (105 mg, 47.0 μmol) and triethylamine (678 μL) were dissolved in dimethysulfoxide (5 mL) and added to DOTA-NHS (481 mg, 959 μmol) dissolved in dimethysulfoxide (40 mL). The mixed solution was stirred at room temperature for 4 days under an argon atmosphere until the reaction was completed using 9 ninhydrin test. Then, the compound was purified by dialysis against distilled water using a Spectra/Por Ⓡ dialysis membrane (MWCO:1000Da) and obtained by freeze-drying. Yield: 182 mg. G1-DL-DOTA was synthesized by the same method using G1-DL (105 mg). Yield: 141 mg.
Preparation of G3-DL-DOTA-Gd and G1-DL-DOTA-Gd
G3-DL-DOTA-Gd was prepared by chelate formation between G3-DL-DOTA and Gd 3+ .
Typical procedure was as follows. G3-DL-DOTA (72.4 mg, 14.9 μmol) was dissolved in water (10 mL) and the solution was added to GdCl 3 (314 mg, 1.19 mmol) dissolved in water.
The pH of the mixed solution was adjusted to be 7.3 with an aliquot of NaOH solution and sonicated at 50 ºC for 150 min under an argon atmosphere using a bath-type sonicator. Then, the G3-DL-DOTA-Gd was purified by dialysis against distilled water using a Spectra/Por Ⓡ dialysis membrane (MWCO:1000Da) and subsequent centrifugation at 15000 rpm for 2 h, and then recovered by freeze-drying. Yield: 141 mg. G1-DL-DOTA-Gd was prepared by the same procedure by chelate formation between G1-DL-DOTA and Gd 3+ .
Preparation of liposomes
Liposomes were prepared according to the method previously reported [37] . A thin dry membrane of a mixture of EYPC, Chol, copoly(EOEOVE-block-ODVE), and PEG-PE and G3-DL-DOTA-Gd at the molar ratio of 42/42/4/2/5-10 was dispersed in 20 mM Hepes and 150 mM NaCl solution of pH7.4 (HBS, 1 ml) by brief sonication using a bath-type sonicator.
Then, the obtained liposome suspension was extruded through a polycarbonate membrane 10 with a pore size of 50 or 100 nm and purified by dialysis in HBS. For preparation of DOX-loaded liposomes, the EYPC, Chol, copoly(EOEOVE-block-ODVE), and PEG-PE and G3-DL-DOTA-Gd was dispersed in 300mM ammonium sulfate (pH 5.3) by hydrated by brief sonication using a bath-type sonicator. The obtained liposome suspension was extruded through a polycarbonate membrane with a pore diameter of 100 nm and was dialyzed in HBS for formation of pH gradient. Then aqueous DOX solution (10 mg/ml) was added to the liposome suspension at DOX/lipid (g/mol) ratio of 100 and the mixed solution was incubated for 1 h at 30 ºC. Free DOX was removed from the liposome suspension by using a Sepharose 4B column with HBS and the DOX-loaded liposome suspension was kept at 4 ºC until the measurements. EYPC concentration was determined using Phospholipid C Test Wako (Wako Pure Chemical Industries Co., Ltd., Osaka, Japan). Encapsulation efficiency of DOX by liposomes was estimated from absorbance of DOX at 499 nm for the DOX-loaded liposomes dissolved in 0.3 N HCl (50vol%)-ethanol (50 vol%) before and after purification with a Sepharose 4B column [24] .
DOX release from liposomes
The release measurements were performed according to the method previously reported [37] . An aliquot of dispersion of the DOX-loaded liposomes was added into 3 ml of HBS in a quartz cell (final concentration of the lipids 13.3 μM) at a given temperature and the fluorescence intensity of the solution was monitored using a spectrofluorometer (JASCO FP-6200ST). The excitation and monitoring wavelengths were 468 nm and 590 nm,
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respectively. The percent release of DOX from liposomes was defined as
where F t and F f are intermediary and final fluorescence intensities of the vesicle suspension at a given temperature. F f was obtained as the fluorescent intensity of the liposome suspension after rupture of liposomes was induced by the addition of 10 % Triton X-100 solution (30μl).
Because DOX was released very quickly above 40 ºC, it was difficult to estimate initial fluorescence intensity of the DOX-loaded liposome suspension. We took the initial fluorescence intensity of the suspension at 10 ºC, where release of DOX was negligible and DOX fluorescence was strongly quenched.
Relaxivity
The T 1 of Gd (0-1.14 mM) for Gd-DOTA-containing molecules and liposomes in HBS were evaluated using a 7T MR scanner (magnet: Kobelco and Jastec, Japan, Console:
Bruker-Biospin, Germany) using the following imaging sequence and parameters: 2D single-slice fast spin-echo sequence (rapid acquisition with relaxation enhancement) with inversion recovery, echo time (TE)=9.60 ms, repetition time (TR)=10000 ms, inversion time=50.5, 100, 200, 400, 800, 1600, 3200 and 6400 ms, field of view (FOV) = 51.2 x 51.2 mm 2 , slice thickness=2.0 mm, and RARE factor=4.
In Vivo MR imaging
Tumor-bearing mice were prepared by inoculating mouse colon carcinoma 26 cells Contrast-enhanced T 1 -weighted images of mice were taken with the 7T MR scanner using the following imaging sequence and parameters: TE=9.57 ms, TR=300 ms, FOV=44.8 x 44.8 mm 2 , slice thickness=1.0 mm, and number of aquesition=4.
Anti-tumor effect of DOX-loaded liposomes
Anti-tumor effect of DOX-loaded liposomes was examined as previously reported [37, 39] . Tumor-bearing mice were prepared by inoculating mouse colon carcinoma 26 cells Where L is the longest dimension parallel to the skin surface and W is the dimension perpendicular to L and parallel to the surface. 13 
Other methods
Differential scanning calorimetry (DSC) was performed with a DSC 120 microcalorimeter (Seiko Electronics). The size of liposomes was evaluated by dynamic light scattering using an Nicomp 380 ZLS instrument (Particle Sizing System, Santa Barbara, CA).
Coupled plasma optical emission spectroscopy measurement was performed using SPS7800
(Seiko Instruments Inc.)
Results and discussion
Preparation of dendron-based lipid having Gd chelates
We prepared the dendron-based lipid, G3-DL-DOTA-Gd, according to Figure 2 . First, PAMAM G3-DL was reacted with 20 eq. of DOTA-NHS, which corresponds to 2.5 eq. of DOTA-NHS per terminal primary amine of the dendron moiety to obtain G3-DL-DOTA. 1 H NMR spectra of DOTA, G3-DL, and G3-DL-DOTA were shown in Figure 3 . The NMR Figure 2 . Synthetic route for G3-DL-DOTA-Gd.
14 spectrum of obtained G3-DL-DOTA contained peaks around 0.9-1.4 ppm and 3.3 ppm, which are derived from G3-DL, and a peak around 3.1 ppm, which is derived from DOTA, indicating that the obtained G3-DL-DOTA actually consisted of G3-DL and DOTA moieties.
However, significant overlap of peaks derived from both G3-DL and DOTA abound 2.2-3.0 ppm made accurate determination of the number of the incorporated DOTA per G3-DL difficult, although it was evaluated to be 7.0 from the integration of these peaks. We further tried to estimate the number of DOTA residues in G3-DL-DOTA by evaluating the number of the residual primary amine groups. T he fluorescamine assay [40] revealed that the number of primary amines remaining in G3-DL-DOTA molecule was estimated to be 0.12 using a calibration curve made with G3-DL as the standard. This result suggests that essentially every chain terminal of the dendron moiety was combined with DOTA residue in G3-DL-DOTA. In the same way, the numbers of residual primary amines were 0.13, indicating that essentially every chain end was connected to DOTA residue in G1-DL-DOTA. These DOTA-incorporated dendron-based lipids were incubated with Gd 3+ for their chelate formation. The numbers of Gd 3+ in G3-DL-DOTA-Gd and G1-DL-DOTA-Gd were 7.8 and 1.6, respectively, using inductively coupled plasma optical emission spectroscopy. 
Relaxivity of copoly(EOEOVE-block-ODVE)-modified liposomes containing
Gd-DOTA-dendron-based lipids
We recently showed that incorporation of copoly(EOEOVE-block-ODVE) to pegylated EYPC/Chol liposomes generates highly temperature-sensitive liposomes, which release encapsulated DOX immediately responding to mild heating [37] . Based on this result, we attempted to prepare multifunctional liposomes by incorporation of Gd-DOTA-dendron-based lipids into the copolymer-modified pegylated liposomes. The potency of MRI contrast agents depends on their ability to shorten the T 1 and T 2 relaxation times of water. The Gd 3+ ions are known to shorten T 1 relaxation time efficiently and hence their chelates have been used as the so-called T 1 -agents for contrast-enhanced T 1 -weighted imaging [2] . For highly sensitive detection of liposomes containing the Gd-DOTA-dendron-based lipids in the body, these liposomes must exhibit a high ability to shorten T 1 relaxation time, which is expressed longitudinal relaxivity r 1 . Therefore, we evaluated the r 1 values of Gd-DOTA-dendron-based was also evaluated to be 4.6 mM -1 s -1 . Although the attachment of Gd-DOTA to G1 dendron moiety of the dendron-based lipid did not affect its ability to shorten T 1 , its attachment to G3 dendron moiety increased the potency of Gd-DOTA to some extent. It was reported that the r 1
for Gd-DOTA-conjugated PAMAM dendrimers increased with the dendrimer generation, because of the increase of rotational correlation time of the whole molecule, which increases with the molecular weight, and limited internal rotational motions of Gd-DOTA moieties connected to the rather rigid backbone of the dendrimer [41] . Therefore, it is likely that the Gd-DOTA residues attached to larger G3 dendron with highly crowded chain terminals might decrease their mobility and increase their rotational correlation time, resulting in higher relaxivity of the G3-DL-DOTA-Gd than G1-DL-DOTA-Gd. In addition, G3-DL-DOTA-Gd retained the high relaxivity when incorporated into the liposomes, suggesting their high detectability in the body with MRI. 17 
In vivo MR imaging of copoly(EOEOVE-block-ODVE)-modified liposomes containing
Gd-DOTA-dendron-based lipids
Detection of the Gd-DOTA-incorporated liposomes in vivo using MRI was examined.
Two kinds of the liposomes consisting of EYPC, Chol, PEG5000-PE, copoly(EOEOVE-block-ODVE, and G3-DL-DOTA-Gd at the mol ratio of 42/42/4/2/10 with average diameters of 110 and 48 nm were prepared by the extrusion method using membranes with a pore size of 100 nm or 50 nm. These liposomes were administrated intravenously to poor liposome accumulation coexist in the tumor sites, which might be reflected from local disparity in the tumor tissue composition, tissue anatomy and vascularization [42, 43] We attempted to detect difference in the tumor accumulation efficiency between these liposomes using MRI. Because MR images of these liposomes were taken using different mice, their MR signal intensities were normalized to those of muscle, where distribution of liposomes might be negligible, for each mouse. 
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tumor site through the EPR effect [44, 45] which is based on the enhanced permeability of blood vessels in the tumor tissues. Therefore, it seems likely that the larger tumor might contain more capillary vessels with higher permeability to the liposomes than the smaller tumor, resulting in more efficient accumulation of the liposomes at the larger tumor.
We also examined whether MR signal intensity at the tumor site is proportional to the amount of Gd 3+ or not. The increase in reciprocal of T 1 is proportional to the increase in the concentration of Gd 3+ ion. Therefore, the increase in MR signal intensity of the right tumor was plotted against the increase in the reciprocal of T 1 ( Figure 7 ). Apparently, these plots are fit on a straight line, indicative of linear relationship between them. The result demonstrates that MR signal intensity at the tumor is proportional to Gd 3+ ion concentration at the tumor site, and hence accumulation of the liposomes bearing Gd 3+ ion can be accurately traced by following MR signals. Finally, we examined the performance of the copolymer-modified pegylated liposomes containing G3-DL-DOTA-Gd as drug delivery system for tumor-specific chemotherapy from the viewpoint of anti-tumor effect by the delivered drug. We used the copolymer-modified pegylated liposomes with G3-DL-DOTA-Gd content of 5% for this experiment because they showed excellent temperature-controlled DOX release behavior (Figure 8 ). ( Figures 5 and 6 ), the tumor site was locally heated at 44°C for 10 min at 8 h after the administration using a radio frequency oscillator as previously reported [37, 39] . Control experiments were also done to the tumor-bearing mice with or without heating at 44°C for 10 min using the same procedure.
Tumor-specific DOX delivery by copoly(EOEOVE-block-ODVE)-modified pegylated
As depicted in Figure 9 , the local heating at 44 °C for 10 min hardly affected tumor growth in comparison with the saline-injected mice without local heating. We have already reported that effect of local heating is at a negligible level, because the 10-min heating might be too short to generate the tumor-growth-suppressive effect of hyperthermia [37] . When the DOX-loaded liposomes were injected to the tumor-bearing mice and local hyperthermia was not applied, the tumor grew quite quickly as the mice that had been injected with saline.
However, when the tumor site was heated at 44°C for 10 min, the tumor growth was strongly suppressed and tumor was even shrunk with time. Because the liposomes retained DOX in the inner space, those accumulating at the tumor might hardly affect its growth. However, when mild heating was applied to the tumor site, DOX molecules were immediately released from the liposomes and attacked to the tumor cells, resulting in shrinking of tumor volume.
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To date, various types of drug carriers having imaging functions have been designed.
Some of these carriers work simply as "dual purpose systems" for both chemotherapy and diagnosis. However, multifunctional carriers having stimuli-responsive drug release and imaging functions have possibility to increase efficacy of chemotherapy, in which information of accumulation of the carriers at the target tissues can enhance bioavailability of drug through application of stimuli to the target sites at the best timing. Temperature-sensitive liposomes having imaging functions are most intensively studied from the practical viewpoint.
For example, water soluble Gd-chelates [46] and Mn 2+ [47] [48] [49] were loaded into lysolipid-based temperature-sensitive liposomes for quantification and monitoring of the drug release process in the target tissues. Because these liposomes were heated in the initial stage 
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of the liposome administration (0-15 min after the administration), the liposome distribution at the tumor was monitored in a short period of 90 min [47, 48] .
We have shown that the copoly(EOEOVE-block-ODVE)-modified pegylated DOX-loaded liposomes were stable at physiological temperature and hence they still retained the ability to attack strongly the tumor even after 12 h after their administration upon mild heating at the tumor [37] . Therefore, it is of importance to follow accumulation process of our liposomes for the long time period, which enables optimization of drug delivery to maximize therapeutic efficacy of drugs. Our liposomes having Gd-chelate-dendron-based lipid exhibited both the highly temperature-responsive drug release and the sensitive MR imaging functions.
These multifunctional liposomes can provide information on the location of tumor sites and the accumulation process of liposomes at the tumor sites. Based on information, drug molecules can be released at the tumor sites by heating the tumor sites at the best timing, resulting in highly efficient therapeutic effect of drug. In addition, the imaging function of the liposomes can be used to optimize liposome characters, such as liposome compositions and liposome size, for better accumulation at the tumor sites through preliminary administration with the liposomes without drug. Indeed, characters of tumors should vary depending on individual patients, but the multifunctional liposomes might lead to an effective chemotherapy optimized to individual patient.
Conclusion
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We developed a new type of multifunctional liposomes having temperature-responsive drug release and MR imaging functions by using a temperature-sensitive copoly(EOEOVE-block-ODVE) and newly synthesized Gd-chelate-attached dendron lipid.
The liposomes provided MR image with high resolution and hence their accumulation process were able to be followed by MRI. The liposomes were stable at physiological temperatures, but exhibited a significant release of encapsulated doxorubicin (DOX) after mild heating. In addition, the liposomes encapsulating DOX injected intravenously into tumor-bearing mice strongly suppressed tumor growth only when the tumor site was heated to 44°C for 10 min at 8 h after injection. The multi-functional liposomes having temperature-triggered drug release and MRI functions may lead to personalized chemotherapy, which is optimized to individual patient.
